The American Academy of Pediatrics has released new information to improve long-acting reversible contraception (LARC) access for teenagers.
Apart from the intended use of LARC to prevent pregnancy in teenagers, they have also proved to be useful in treating HMB and AUB. Recent studies have also shown that LARC can be used to treat endometriosis pain.
Similarly, LARC may even lower symptoms of depression in adolescents and young adults.
The American Academy of Pediatrics (AACP) has recently issued a clinical report to provide pertinent information about improving access to LARC in teens.
The report includes several crucial topics, such as taking time to discuss expected side effects, changes to bleeding patterns and reminding patients that condoms are still needed to protect patients against STIs.
For the full list of recommendations, read additional coverage from our sister publication Contemporary Pediatrics.
PCOS and irregular cycles tied to cardiometabolic risks
May 15th 2024A comprehensive analysis reveals strong associations between polycystic ovary syndrome, irregular menstrual cycles, and increased risks of cardiometabolic conditions, underscoring the importance of proactive screening and intervention strategies.
Read More
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More